The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Bruker's revenues will expand 1.4% and EPS will increase 16.7%.
The average estimate for revenue is $426.4 million. On the bottom line, the average EPS estimate is $0.14.
Last quarter, Bruker booked revenue of $393.4 million. GAAP reported sales were 3.0% lower than the prior-year quarter's $405.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.08. GAAP EPS of $0.03 for Q1 were 67% lower than the prior-year quarter's $0.09 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 44.4%, 250 basis points worse than the prior-year quarter. Operating margin was 4.7%, 460 basis points worse than the prior-year quarter. Net margin was 1.4%, 230 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $1.82 billion. The average EPS estimate is $0.81.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 249 members out of 265 rating the stock outperform, and 16 members rating it underperform. Among 53 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 51 give Bruker a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Bruker is outperform, with an average price target of $20.50.
Looking for alternatives to Bruker? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Bruker to My Watchlist.